NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,453 | -60.3% | 176 | -57.2% | 0.00% | -50.0% |
| Q2 2023 | $41,472 | -44.8% | 411 | -49.7% | 0.01% | -50.0% |
| Q1 2023 | $75,130 | +102.0% | 817 | +99.3% | 0.02% | +100.0% |
| Q4 2022 | $37,195 | +32.8% | 410 | +10.8% | 0.01% | +14.3% |
| Q3 2022 | $28,000 | -9.7% | 370 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $31,000 | +138.5% | 370 | +146.7% | 0.01% | +166.7% |
| Q1 2022 | $13,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $13,000 | +85.7% | 150 | +87.5% | 0.00% | +50.0% |
| Q3 2021 | $7,000 | 0.0% | 80 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $7,000 | 0.0% | 80 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | -56.2% | 80 | -56.8% | 0.00% | -60.0% |
| Q3 2020 | $16,000 | -11.1% | 185 | -11.9% | 0.01% | -28.6% |
| Q2 2020 | $18,000 | – | 210 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |